CVS Health (CVS) Stock Rallies 3.7% on Analyst Upgrade
Published on Β· Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowCVS Health (CVS) shares increased as much as 3.7% on Tuesday morning, currently up 3.4%. This surge is attributed to a positive rating from Jefferies analyst Brian Tanquilut, who set a $120 price target indicating 28% upside. The forecast includes an expected earnings per share (EPS) of at least $8.44 for 2027. CVS's recent increase in full-year guidance suggests strong growth potential, making its stock appealing for investors monitoring healthcare sector movements.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About CVS Health Corporation (CVS)
CVS Health operates retail pharmacies, a pharmacy-benefits manager, and the Aetna insurance business.
The Health Care sector covers pharmaceutical, biotech, device and managed-care companies.
Earlier CVS news
- CVS Health (CVS) Earnings Report Upcoming Analysts Focus on GLP-1
- CVS (CVS) Reports 3% Net Income Margin, $100.4 Billion Revenue
- BlackRock Boosts CVS Group (CVS) Stake to 5% Ownership
- BlackRock Stake in CVS (CVS) Falls Below 5% Amid Market Changes
- Crisis and Resilience Fund Offers Β£300,682 for Financial Support
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
S&P 500 and Nasdaq Rise as AI Stocks Rebound Before Earnings
Oct 19
A&W (TSX:AW) Q3 Results Show Margin Squeeze Impact
Oct 18